[Neuro-hormonal regulation of aqueous humor dynamics as the basis of glaucoma pharmacotherapy. Part I. Aqueous humor secretion].
The aim of this article is to present current opinion on aqueous humor dynamics regulation and antiglaucoma drugs mechanisms of action. Glaucoma pharmacotherapy is based mainly on neuro-hormonal processes controlling aqueous humor dynamics. Systemic hormones as well as local hormones and autonomic nervous system mediators are involved in the processes of aqueous humor formation and drainage. Antiglaucoma medications act mainly through activation or inhibition of these systems' receptors, helping to decrease aqueous humor production or improve aqueous humor outflow. In this article (part 1) we describe three groups of antiglaucoma medications (beta-antagonists, adrenergic agonists, carbonic anhydrase inhibitors), inhibiting the aqueous humor production and mechanisms of their hypotensive effect in the eye.
Kliniki Okulistyki Centrum Medycznego Kształcenia Podyplomowego w Warszawie.
Barbara
B
Terelak-Borys
Iwona
I
Liberek
D000322:Adrenergic Agonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001082:Aqueous Humor / Q000187:drug effects / Q000378:metabolism*; D001341:Autonomic Nervous System / Q000187:drug effects / Q000378:metabolism; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D005901:Glaucoma / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D018377:Neurotransmitter Agents / Q000378:metabolism
D000322:Adrenergic Agonists; D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D018377:Neurotransmitter Agents